Evidence map›Paper›PMID 26136410›Full record

ArticleJournal of cachexia, sarcopenia and muscle2015

Improved body weight and performance status and reduced serum PGE2 levels after nutritional intervention with a specific medical food in newly diagnosed patients with esophageal cancer or adenocarcinoma of the gastro-esophageal junction.

Joyce Faber, Madeleen J Uitdehaag, Manon Spaander, Sabine van Steenbergen-Langeveld, Paul Vos, Marloes Berkhout, Cor Lamers, Hans Rümke, Hugo Tilanus, Peter Siersema and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of cachexia, sarcopenia and muscle, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Review
  8. Cancer cachexia: A scoping review on non-pharmacological interventions.Asia-Pacific journal of oncology nursing · 2024
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Moving upwards - the journal of cachexia, sarcopenia and muscle in 2016.Journal of cachexia, sarcopenia and muscle · 2016
    Article
  18. Article
  19. Protein anabolic resistance in cancer: does it really exist?Current opinion in clinical nutrition and metabolic care · 2016
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Joyce FaberNutricia Research, Nutricia Advanced Medical Nutrition, Utrecht, The Netherlands.
Madeleen J UitdehaagDepartment of Gastroenterology, Erasmus Medical Center, Rotterdam, The Netherlands.
Manon SpaanderDepartment of Gastroenterology, Erasmus Medical Center, Rotterdam, The Netherlands.
Sabine van Steenbergen-LangeveldLaboratory of Experimental Tumor Immunology, Department of Medical Oncology, Erasmus MC- Cancer Institute, Rotterdam, The Netherlands.
Paul VosNutricia Research, Nutricia Advanced Medical Nutrition, Utrecht, The Netherlands.
Marloes BerkhoutNutricia Research, Nutricia Advanced Medical Nutrition, Utrecht, The Netherlands.
Cor LamersLaboratory of Experimental Tumor Immunology, Department of Medical Oncology, Erasmus MC- Cancer Institute, Rotterdam, The Netherlands.
Hans RümkeVaxinostics BV, University Vaccine Center Rotterdam Nijmegen, Rotterdam, The Netherlands.
Hugo TilanusDepartment of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.
Peter SiersemaDepartment of Gastroenterology, Erasmus Medical Center, Rotterdam, The Netherlands.
Ardy van HelvoortNutricia Research, Nutricia Advanced Medical Nutrition, Utrecht, The Netherlands.
Ate van der GaastDepartment of Medical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands.
Erasmus MC · NLNutricia Research (Netherlands) · NLErasmus MC Cancer Institute · NLUtrecht University · NLRotterdam University of Applied Sciences · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe majority of cancer patients loses weight and becomes malnourished during the course of their disease. Metabolic alterations and reduced immune competence lead to wasting and an increased risk of infectious complications. In the present study, the effect of a nutritionally complete medical food, which is high in protein and leucine and enriched with fish oil and specific oligosaccharides, was investigated on immune function, nutritional status, and inflammation in patients with esophageal cancer and compared with routine care.

methodsIn this exploratory double-blind study, 64 newly diagnosed esophageal cancer patients were randomized. All patients received dietary counselling and dietary advice. In the Active group, all patients received the specific medical food for 4 weeks before the start of anticancer therapy. In the routine care control arm, patients with <5% weight loss received a non-caloric placebo product, and patients with weight loss ≥5% received an iso-caloric control product to secure blinding of the study. The required study parameters of body weight and performance status were recorded at baseline and after 4 weeks of nutritional intervention, and patients were asked to complete quality of life questionnaires. In addition, blood samples were taken for the measurement of several immune, nutritional, and safety-parameters.

resultsNo effect of the specific nutritional intervention could be detected on ex vivo stimulations of blood mononuclear cells. By contrast, body weight was significantly increased (P < 0.05) and ECOG performance status was improved after intervention with the specific medical food (P < 0.05). In addition, serum Prostaglandin E2 (PGE2) levels were significantly decreased in the specific medical food group and increased in the control group (P = 0.002).

conclusionsNutritional intervention with the specific medical food significantly increased body weight and improved performance status compared with routine care in newly diagnosed esophageal cancer patients. This effect was accompanied by significantly reduced serum PGE2 levels.

Indexed as

Body weightCancerClinicalMedical foodNutritionPGE2

Identifiers

PMID26136410
PMCPMC4435095
OpenAlexW1893179102

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.